GLYCOCALICIN DERIVED PEPTIDES INHIBIT von WILLEBRAND FACTOR BINDING TO PLATELETS

By Williams S.B.   Krutzsch H.   McKeown L.P.   Gralnick H.R.  

Thrombosis Research, Vol. 86, Iss. 5, 1997-06 ,pp. : 417-421

Elsevier

Access to resources Recommend Favorite

Prognostic value of plasma von willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation

By Conway D.S.G.   Pearce L.A.   Chin B.S.P.   Hart R.G.   Lip G.Y.H.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 15-15

Elsevier

Access to resources Recommend Favorite

VON WILLEBRAND FACTOR ANTIGEN IN BLOOD PLASMA OF PATIENTS WITH URINARY BLADDER CARCINOMA

By Zietek Z.   Iwan-Zietek I.   Paczulski R.   Kotschy M.   Wolski Z.  

Thrombosis Research, Vol. 83, Iss. 5, 1996-09 ,pp. : 399-402

Elsevier

Access to resources Recommend Favorite

Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients

By Koo B.-H.   Oh D.   Chung S.Y.   Kim N.K.   Park S.   Jang Y.   Chung K.-H.  

Thrombosis Research, Vol. 105, Iss. 6, 2002-03 ,pp. : 471-476

Elsevier

Access to resources Recommend Favorite

Von Willebrand Factor in Plasma of Patients with Advanced Stages of Larynx Cancer - Evidence for presence of specific binding sites and modification of von Willebrand factor structure and function

By Paczuski R.   Bialkowska A.   Kotschy M.   Burduk D.   Betlejewski S.  

Thrombosis Research, Vol. 95, Iss. 4, 1999-08 ,pp. : 197-200

Elsevier

Access to resources Recommend Favorite